Zenas BioPharma, Inc.
ZBIO
$25.87
$1.204.86%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -80.99M | -240.44M | -51.50M | -52.22M | -33.57M |
| Total Depreciation and Amortization | 6.00K | 10.00K | 11.00K | 12.00K | 23.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.65M | 179.70M | 14.03M | 5.31M | 5.36M |
| Change in Net Operating Assets | -9.86M | 8.32M | -3.66M | 5.16M | -8.86M |
| Cash from Operations | -75.20M | -52.41M | -41.13M | -41.74M | -37.05M |
| Capital Expenditure | -2.00K | 0.00 | 0.00 | 0.00 | -18.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 31.61M | -93.36M | 40.04M | -112.29M | -86.26M |
| Cash from Investing | 31.61M | -93.36M | 40.04M | -112.29M | -86.27M |
| Total Debt Issued | 267.50M | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 166.49M | 150.18M | 940.00K | 1.72M | 99.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -512.00K | -9.34M | 71.68M | -- | -- |
| Cash from Financing | 433.48M | 140.84M | 72.62M | 1.72M | 99.00K |
| Foreign Exchange rate Adjustments | -311.00K | 11.00K | 25.00K | -236.00K | -52.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 389.58M | -4.92M | 71.56M | -152.55M | -123.28M |